Who Is Breast Cryoablation Appropriate For?
Breast Cryoablation may be an appropriate treatment for cancers that are:
- Low Grade
- Tumor size 3 cm or less
- Have no lymph node involvement
- Invasive with less than 25% Ductal Carcinoma in situ (DCIS)
- Have no skin or nipple involvement
Dr. Barclay-White is a Principal Investigator in the FROST (Freezing Alone Instead of Resection Of Small Tumors) clinical trial, sponsored by Sanarus. This is a national study of the use of cryoablation in management of early-stage breast cancer. Women who meet the following criteria may be eligible to participate:
- Age 50 years or older
- Have had a needle biopsy of the cancer showing Invasive Ductal Carcinoma
- Have had a needle biopsy of the cancer showing it is estrogen sensitive
- Have cancer that is visible by ultrasound
- Have cancer that measures 2.0 cm or less by mammogram, ultrasound and MRI
- Be physcially and emotionally able to complete follow-up biopsy, MRIs, endocrine therapy and/or radiation (radiation is required for participants age 50-69).